Jessica M Heijdra

7PUBLICATIONS
13CO-AUTHORS
HaematologyDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 03, 2022
Desmopressin testing in von Willebrand disease: Lowering the burden.

Jessica M Heijdra, Ferdows Atiq, Wala Al Arashi

|May 08, 2022
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.

Jessica M Heijdra, Michael E Cloesmeijer, Nico C B de Jager

|Apr 21, 2022
Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease.

Ferdows Atiq, Jessica Heijdra, Fleur Snijders

|Feb 16, 2022
Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study.

Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager

|Sep 27, 2019
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P® /Humate P® treatment in von Willebrand disease patients.

Nico C B de Jager, Laura H Bukkems, Jessica M Heijdra

|Mar 25, 2018
Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment.

H C A M Hazendonk, J M Heijdra, N C B de Jager

Pageof 2

Frequent Collaborators

4 joint publications

Frank W G Leebeek

3 joint publications

Marjon H Cnossen

2 joint publications

Ferdows Atiq

2 joint publications

Karina Meijer